Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Pandemic lockdowns reduced selfie-related fatalities despite social media surge

The COVID-19 pandemic led to a significant decrease in selfie-related deaths, even as social media usage spiked. The study suggests that lockdowns and travel restrictions limited opportunities for risky selfies, highlighting the need for new preventative strategies.

27 Sep 2023

New material more efficient at capturing coronavirus proteins with minimal impact on breathability

A research team at the University of Liverpool has developed a new material that captures coronavirus particles and could transform the efficiency of face masks and other filter equipment to stop the spread of COVID-19 and other viruses.

26 Sep 2023

Can training to suppress thoughts improve mental health? Study challenges century-old wisdom

Researchers describe the effects of thought suppression on mnemonic, affective, positive, or negative mental health indices.

26 Sep 2023

How the COVID-19 pandemic affected mental well-being of UK secondary school students

Researchers evaluated the impact of COVID-19 on the mental health of secondary school children in the UK.

26 Sep 2023

How does long covid impact the school experiences of children and young people?

The impact of long covid on school experiences.

26 Sep 2023

One health wake-up call: London's river data highlights environmental perils

The largest-ever spatiotemporal monitoring of chemicals/contaminants of emerging concern (CECs) in London waterways.

26 Sep 2023

Hospitalized COVID-19 patients face triple the risk of multiorgan damage, study reveals

Researchers in the U.K. find that patients hospitalized with COVID-19 face a higher medium-term risk of multiorgan abnormalities, revealed through multiorgan MRI scans. The study emphasizes the urgency for comprehensive post-hospitalization care, as these abnormalities are associated with persistent mental and physical health impairments.

25 Sep 2023

Intranasal vaccine shows promise against COVID variants in hamsters

Intranasal mRNA-LNP vaccines show promise in Syrian golden hamsters, effectively reducing SARS-CoV-2 viral loads and lung pathology. The study suggests potential efficacy against new variants, setting the stage for future research in human applications.

25 Sep 2023

One gene variant could be a shield against severe COVID-19 lung damage

Researchers identify a specific genetic variant, rs2204985, linked to less severe lung involvement and a stronger immune response in COVID-19 patients with severe pneumonia. The study suggests that understanding this genetic marker could help identify high-risk individuals and enhance strategies for prevention and treatment.

25 Sep 2023

Future-proof vaccine candidate protects against wide range of coronaviruses

Studies of a 'future-proof' vaccine candidate have shown that just one antigen can be modified to provide a broadly protective immune response in animals.

25 Sep 2023

Is the implementation of contact precautions crucial for preventing healthcare-associated MRSA?

The designation of contact precautions as an "essential practice" for MRSA prevention.

25 Sep 2023

Diabetes incidence significantly increased among youth during COVID-19 pandemic

Diabetes incidence among youth in the United States before and during the coronavirus disease 2019.

25 Sep 2023

The power of nanobodies: How they impact COVID-19 immune response

The structures of 340 antibodies (Abs) and 83 nanobodies.

25 Sep 2023

COVID-19 pushed upstate New Yorkers to embrace backyard farming

During the COVID-19 pandemic, upstate New Yorkers turned to backyard and wild food production to gain more control over their food supply, according to a study by Cornell University. The research highlights how the pandemic-related disruptions in conventional food supply chains led to a significant uptick in gardening, poultry rearing, and foraging as a strategy to improve food security.

25 Sep 2023

How are SARS-CoV-2 variants outsmarting our immune system and vaccines?

Researchers use multiomics analysis to understand how SARS-CoV-2 variants, including Alpha, Delta, and Omicron, modulate the host's cellular responses and adapt to evade human immunity. The study highlights the potential for targeted therapies against both adaptive and innate immune responses.

25 Sep 2023

Has the COVID-19 pandemic widened the mental health gap in the UK?

The study explores the varying mental health impacts of the COVID-19 pandemic on the UK's adult population, revealing increased inequalities and distress. Utilizing both surveys and focus group discussions, the research emphasizes the urgent need for targeted interventions and policy responses to address deteriorating mental health and growing disparities.

24 Sep 2023

Could creatine supplementation be the answer to post-COVID-19 fatigue?

In a recent study published in the journal Food Science & Nutrition, researchers investigated creatine supplementations as a potential intervention strategy to attenuate the clinical symptoms of post-COVID-19 fatigue syndrome.

22 Sep 2023

Can COVID-19 vaccines turn the tide on long-haul symptoms?

The study finds that COVID-19 vaccination can significantly reduce symptoms and improve well-being in patients suffering from post-COVID-19 conditions (PCC). Vaccination also lowered systemic markers of inflammation but did not entirely eliminate persistent SARS-CoV-2 antigens, which may continue to contribute to inflammation.

22 Sep 2023

Long COVID sidelining doctors and putting careers at risk, says alarming BMJ study

Doctors grappling with long COVID face significant career setbacks and inadequate workplace protection, according to a recent BMJ study. Co-founded by a doctor who contracted long COVID, advocacy group Long COVID Doctors for Action pushes for better support and recognition of the condition as an occupational disease.

21 Sep 2023

Inhaled fluticasone furoate falls flat in speeding up COVID-19 recovery, says ACTIV-6 trial

The ACTIV-6 trial investigated the effectiveness of inhaled fluticasone furoate on mild-to-moderate COVID-19 cases and found it did not accelerate recovery or prevent clinical progression compared to a placebo. Interestingly, vaccinated participants showed slightly faster recovery when treated with the drug, while unvaccinated participants did not.

21 Sep 2023